Published in Blood Weekly, October 16th, 2003
The new findings emerged from a large international clinical trial called Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE). The study tested a combination of two antiplatelet agents that help prevent blood clots: aspirin and clopidogrel. CURE participants had unstable angina.
Blood clots are a major cause of heart attacks and strokes.
The main goal of the trial was to test the effectiveness of clopidogrel and aspirin vs. aspirin alone. CURE researchers reported last year...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.